Cost-utility of implantable tibial neuromodulation (Revi) versus conservative therapy for urgency urinary incontinence in adults: a US payer perspective

Cindy L. Amundsen, Suzette E. Sutherland, Sara M. Lenherr, Paul J. Niklewski, Peter R. Rodine, Roger R. Dmochowski

Open source

DOI
10.1080/13696998.2026.2655592
Published
2026-04-21
Container
Journal of Medical Economics
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/13696998.2026.2655592,
  title = {Cost-utility of implantable tibial neuromodulation (Revi) versus conservative therapy for urgency urinary incontinence in adults: a US payer perspective},
  author = {Cindy L. Amundsen and Suzette E. Sutherland and Sara M. Lenherr and Paul J. Niklewski and Peter R. Rodine and Roger R. Dmochowski},
  year = {2026},
  journal = {Journal of Medical Economics},
  doi = {10.1080/13696998.2026.2655592},
  url = {https://doi.org/10.1080/13696998.2026.2655592}
}

RIS

TY  - JOUR
TI  - Cost-utility of implantable tibial neuromodulation (Revi) versus conservative therapy for urgency urinary incontinence in adults: a US payer perspective
AU  - Cindy L. Amundsen
AU  - Suzette E. Sutherland
AU  - Sara M. Lenherr
AU  - Paul J. Niklewski
AU  - Peter R. Rodine
AU  - Roger R. Dmochowski
PY  - 2026
JO  - Journal of Medical Economics
DO  - 10.1080/13696998.2026.2655592
UR  - https://doi.org/10.1080/13696998.2026.2655592
ER  - 

APA

Amundsen, C. L., Sutherland, S. E., Lenherr, S. M., Niklewski, P. J., Rodine, P. R., & Dmochowski, R. R. (2026). Cost-utility of implantable tibial neuromodulation (Revi) versus conservative therapy for urgency urinary incontinence in adults: a US payer perspective. Journal of Medical Economics. https://doi.org/10.1080/13696998.2026.2655592

Source records